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Abstract
Objective—To examine ADHD symptom persistence and factors associated with elevated 
symptom counts in a diverse, longitudinal community-based sample.
Method—Parents reported demographics and completed a diagnostic interview repeatedly over a 
6-year period. At Time 1, 481 interviews were completed about children (5–13 years); all 
participants were invited to four annual follow-up interviews, and 379 (79%) completed at least 
one. Inattentive (IA) and hyperactive-impulsive (HI) symptom counts were modeled with logistic 
quantile regression, while accounting for study design complexities.
Results—The prevalence of seven IA symptoms remained stable from early childhood through 
late adolescence. The prevalence of eight HI symptoms decreased by more than half over time. 
After demographic adjustment, the upper quartile of HI symptom counts decreased with age (p < .
01). High HI symptom counts persisted more among those with high IA symptom counts (p = .05).
Conclusion—This study further characterizes and provides insights into ADHD symptom 
trajectory through adolescence.
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ADHD is one of the most common behavioral disorders of childhood, affecting an estimated 
5% to 11% of youth in the community (Akinbami, Liu, Pastor, & Reuben, 2011; Centers for 
Disease Control and Prevention, 2010; Scahill & Schwab-Stone, 2000; Visser et al., 2014; 
Wolraich et al., 2012). Although historically considered a disorder of childhood, ADHD 
research since the 1980s has shown that the disorder often persists into late adolescence and 
into adulthood (Barbaresi et al., 2013). Clinical guidelines have been adjusted to reflect the 
persistence of ADHD symptoms and associated impairment (American Academy of 
Pediatrics’ Subcommittee on Attention-Deficit/Hyperactivity Disorder Steering Committee 
on Quality Improvement and Management, 2011). Persistent ADHD is associated with 
negative outcomes including academic underachievement (Barbaresi, Katusic, Colligan, 
Weaver, & Jacobsen, 2007; Loe & Feldman, 2007), driving violations and motor vehicle 
collisions (Jerome, Segal, & Habinski, 2006), substance use (Molina et al., 2013), sexual 
risk behaviors (Flory, Molina, Pelham, Gnagy, & Smith, 2006), and unemployment (Küpper 
et al., 2012). For this reason, the pattern, timing, and trajectory of ADHD symptoms have 
important implications for providing guidance and developing treatment, management, and 
transition plans for children with ADHD and their families.
Prevalence of the disorder and its persistence throughout development are two prominent 
areas of epidemiologic ADHD research. Prevalence studies utilize data from cross-sectional 
study designs, and estimates have been reported from a variety of epidemiologic data 
sources. National surveys include items on the parent report of health-care-provider-
diagnosed ADHD (Akinbami et al., 2011; Visser et al., 2014), insurance claims have been 
mined to create estimates of diagnosed and treated (medicated) ADHD (Getahun et al., 
2013), and community-based samples have used epidemiologic screening methods and 
direct diagnostic interviews to determine which children meet Diagnostic and Statistical 
Manual of Mental Disorders (DSM) criteria (DSM-IV-TR; 4th ed., text rev.; American 
Psychiatric Association [APA], 2000; DSM-5; 5th ed., APA 2013; Bird et al., 2006; 
Wolraich et al., 2012). Although prevalence estimates vary by ascertainment method, 
assembling results from multiple methodologies creates a more comprehensive picture of the 
underlying and diagnosed prevalence of ADHD in the United States.
Characterizing ADHD persistence is methodologically more complex than estimating the 
disorder’s prevalence. One reason is that it requires an appropriate longitudinal data source. 
As highlighted by Willoughby (2003) and reviewed further by Faraone, Biederman, and 
Mick (2006), early ADHD persistence studies relied on clinic-based samples; this research 
methodology continues, likely due to the ease with which these populations are identified 
(Biederman, Petty, Clarke, Lomedico, & Faraone, 2010). However, findings from clinical 
samples may not be generalizable to the broader community of interest because those with 
low access to health care (Eaton et al., 2008; Goldberg, 1995), low levels of impairment 
(Buitelaar, Kan, & Asherson, 2011; Goodman et al., 1998), and no psychiatric comorbidity 
(Buitelaar et al., 2011) are less likely to be included in clinical samples. Therefore, 
persistence estimates from clinic-based samples may suffer selection biases and should be 
interpreted within the context of research from other population-based studies, when 
possible.
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ADHD persistence can be described at the disorder level (i.e., syndromatic persistence) and 
symptom level (i.e., symptomatic persistence). Previous estimates of syndromatic 
persistence have ranged from 33% (Mannuzza & Gittelman, 1984) to 48% (Rasmussen & 
Gillberg, 2000). Symptomatic persistence has an even larger range in estimates, from 36% 
(Mannuzza & Gittelman, 1984) to 85% (Biederman et al., 1996). Some of the most 
comprehensive research on ADHD persistence comes from Biederman et al. (2010) who 
recently published a thorough report of ADHD persistence patterns using a clinical sample 
of Caucasian boys followed over 10 years into young adulthood. While 45% of baseline 
cases continued to meet full DSM-IV criteria (APA, 1994), 78% met at least one of the 
study’s persistence definitions. This included functional persistence, meaning participants 
had less than half the symptoms required for a full diagnosis but remained functionally 
impaired (Biederman et al., 2010).
There is a need for similar research with community samples, especially those that include 
girls and racial minorities, as very little is known about ADHD persistence patterns among 
these groups (Bauermeister et al., 2011). We are aware of only one study that has utilized a 
non-clinical sample and DSM-IV criteria at baseline and follow-up (Todd et al., 2008). This 
was a twin study focused on ADHD and subtype stability rather than on reporting 
persistence patterns of the disorder or symptoms.
It is also important that ADHD persistence studies continue to recognize inattention (IA) and 
hyperactive-impulsive (HI) trajectories separately, as behavior research suggests differing 
developmental patterns for these sets of behaviors. It is generally understood that disruptive 
behaviors appear a few years before IA symptoms in development (Loeber, Green, Lahey, 
Christ, & Frick, 1992) and HI behaviors tend to decline earlier than the decline of IA 
symptoms in adolescence (Biederman, Mick, & Faraone, 2000; Hart, Lahey, Loeber, 
Applegate, & Frick, 1995).
The goal of this study is to describe DSM-IV ADHD symptom persistence from early 
childhood through late adolescence using a diverse community-based epidemiological 
sample of boys and girls with and without ADHD. Graphics of individual IA and HI 
symptoms and IA and HI symptom counts will be complemented with advanced modeling to 
determine statistical significance of symptom decline after accounting for ADHD 
medication use, psychiatric comorbidity, and other demographic factors.
Method
Sample
This study utilizes data from the Project to Learn about ADHD in Youth (PLAY), a cohort 
study that included sites in South Carolina (SC) and Oklahoma (OK; Wolraich et al., 2012). 
Only SC data were included in this analysis because high retention of the cohort over time 
allowed for an appropriate longitudinal analytic approach. A previous publication which 
focused on the baseline sample from both sites reported an ADHD prevalence estimate of 
8.7% in SC (Wolraich et al., 2012).
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In the first stage of a two-stage sampling design, parents and teachers reported history of an 
ADHD diagnosis and ADHD medication use, and teachers completed the Vanderbilt ADHD 
Diagnostic Teacher Rating Scale (VADTRS; Wolraich, Feurer, Hannah, Baumgaertel, & 
Pinnock, 1998). Children with a previous diagnosis, current medication use, or teacher 
report of ≥6 symptoms and some impairment were categorized as high risk of ADHD. All 
high screened individuals and their parents were eligible for a second-stage interview, as 
well as a sample of low-risk peers, frequency-matched on sex. Further details on sampling 
design have been described previously (Wolraich et al., 2012). All study procedures were 
approved by the Institutional Review Boards of the Centers for Disease Control and 
Prevention and University of South Carolina.
At baseline (2003–2005, hereafter referred to as Time 1), 481 children and their parents 
completed an interview. Beginning 3 years later, all traceable participants were invited for 
annual interviews; 292, 280, 249, and 294 participants were interviewed at the four follow-
up waves, respectively (Times 2–5). In total, 379 participants (79%) were interviewed at 
least once between 3 and 8 years after Time 1. Most interviews were scheduled 2 to 4 weeks 
in advance and confirmed a few days beforehand. All interviews were completed in person 
unless participants had transportation limitations or moved out of the area, in which case 
interviews were completed via telephone. Participants were compensated for their time upon 
completion of each interview; the amount varied as procedures were modified to collect age-
appropriate data. Written informed consent was obtained before interviews at every wave.
Measures
The Diagnostic Interview Schedule for Children Version IV (DISC-IV) is a standardized 
interview designed to assess psychiatric disorders in children (Shaffer, Fisher, Lucas, 
Dulcan, & Schwab-Stone, 2000). As part of each interview, parents completed 10 DISC-IV 
modules, each of which asked questions regarding a separate common psychiatric disorder. 
Questions about inattention, hyperactivity, and impulsivity were asked in the ADHD 
module, including items on symptoms, time frame, and associated functional impairment. 
ADHD case criteria required two intermediate or one severe impairment rating. Questions 
were asked similarly for social phobia, separation anxiety disorder, generalized anxiety 
disorder, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), 
major depression, mania (and hypomania), oppositional defiant disorder, and conduct 
disorder. Moderate to strong test–retest agreement (kappa [κ] from 0.5 to 0.8) has been 
observed for most DISC-IV modules (ADHD module: κ = 0.79; Shaffer et al., 2000). 
Participants were considered to have a psychiatric condition (other than ADHD) if they met 
DISC-IV criteria for a condition and had at least intermediate impairment due to the 
symptoms. The DISC-IV allows for user selection of various impairment thresholds to 
satisfy DSM’s functional impairment criteria.
In our previously published ADHD prevalence study (Wolraich et al., 2012), we also 
incorporated teacher-reported data; however, we did not have teacher-reported data from 
follow-up waves. As a result, prevalence estimates for ADHD are higher in this study than 
in the previous study (Wolraich et al., 2012).
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Information on children’s usage of medication for ADHD was collected as part of each 
DISC-IV interview, as were data on whether the child lived with two parents. All other 
demographic data were collected via questionnaire at each data collection wave.
Analytical Approach
IA and HI symptom counts were found to be positively skewed, with increasing skewness 
from early childhood to late adolescence (IA skewness: 0.50–0.65; HI: 0.71–1.81). The 
distribution of symptom counts informed the approach of subsequent analyses. All analyses 
were performed using R Version 2.14.0 (R Core Team, 2012).
To allow for visual interpretation, symptom counts are displayed by categories of 
developmental stage (early childhood [5–8 years], middle childhood [9–11 years], early 
adolescence [12–14 years], and late adolescence [15–19 years]). These categories were 
selected for their applicability to the data while approximating developmental stages in the 
developmental psychology literature. In this article, developmental stages are only utilized 
for visualization of basic results; all modeling and resulting test statistics treated participant 
age (to the 100th of a year) as a continuous variable. Using age in models rather than 
another time measure yielded estimates whose interpretation directly apply to age itself 
while precisely accounting for time between each participant’s interviews as well as age 
difference across participants.
Logistic quantile regression is a procedure that models specified percentiles, rather than the 
mean, of a dependent variable (Bottai, Cai, & McKeown, 2010). In doing so, no 
assumptions are made about the scale or the distribution of the variable of interest. This 
approach has been shown to perform favorably for bounded outcomes with skewed 
distributions (e.g., symptom counts; Bottai et al., 2010). In this study, logistic quantile 
regression was used to determine whether age (continuous) was associated with particular 
percentiles of IA and HI symptom counts.
Other factors considered in models as being associated with symptom count were race, sex, 
ADHD medication use, presence of psychiatric disorder other than ADHD, and whether two 
parents lived in the household. Models allowed ADHD medication use, psychiatric 
comorbidity, and whether two parents lived in the home to vary over time. Potential 
covariates were removed from all models through a backward stepwise procedure if their 
elimination did not result in a 10% change in any model’s age-associated estimate. The 
standard errors of the regression coefficients were estimated with 200 bootstrapped samples, 
as bootstrapping was shown to outperform other estimators for quantile regression models, 
especially with heteroskedastic data (i.e., variables that have different variances, such as 
symptom count by age; Buchinsky, 1995).
In addition, logistic regression modeling was performed to determine whether high (≥6) HI 
symptom counts were more likely to persist among participants who had high IA symptom 
counts at Time 1, and whether high IA symptom counts were more likely to persist among 
those who had high HI symptom counts at Time 1. All analyses accounted for the 
multistage, stratified study design and the intra-individual correlation between data 
collection waves. Probability weights used in the analyses reflected differential sampling 
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from the underlying school district population and non-response. When applied to the 
interview data, they produced demographic estimates that were close to the observed 
proportions of demographic characteristics in the school district population.
Results
Demographic information of the study sample is displayed in Table 1 by data collection 
wave using unweighted percentages to allow for inspection of differential attrition. The 
subsequent table and figures present weighted statistics. Mean participant age at Times 1 to 
5 were 9.2, 12.5, 13.6, 14.6, and 15.6 years, respectively. Non-Hispanic Whites and non-
Hispanic Blacks were well represented, as were both sexes (67% boys, reflecting a higher 
prevalence of ADHD symptoms in boys compared with girls in the screened sample). 
Meeting criteria for other externalizing and internalizing psychiatric conditions were most 
common at Time 1. At Times 1 to 5, the weighted prevalence estimates and 95% confidence 
intervals (CI) of DISC-IV-defined ADHD were 12.2% (10.2, 14.5), 11.2% (8.9, 13.8), 
12.2% (8.5, 17.1), 6.5% (5.0, 8.4), and 8.4% (6.0, 11.5), respectively. Most demographic 
groups were retained for follow-up in similar proportions, including non-Hispanic Blacks. 
Other racial/ethnic minority participants were less likely to be retained, although this 
difference was not statistically significant.
Figure 1 shows the prevalence of each ADHD symptom by developmental stage (early 
childhood [5–8 years], middle childhood [9–11 years], early adolescence [12–14 years], and 
late adolescence [15–19 years]). Prevalence of individual IA symptoms ranged from 18% to 
45% among early childhood and 20% to 43% among those in late adolescence. Across 
developmental stages, most symptoms were reported at similar levels. There was a 
decreasing trend in prevalence of HI symptoms with increasing child age. The prevalence of 
individual HI symptoms ranged from 18% to 43% among those in early childhood and 6% 
to 18% among late adolescents. Eight of the nine HI symptoms among participants in late 
adolescence were at levels less than half the proportions reported in early childhood.
Figure 2 displays the distribution of each symptom count by symptom type, developmental 
stage, and sex. Cut points are included in the figure to separate those who had six or more 
symptoms and, therefore, were most likely to meet ADHD diagnostic criteria. Neither sex 
had a considerable change in IA symptom count distribution over developmental stages. 
High HI symptom counts appeared to be lower among the older participants, and the rate of 
this decline was fairly similar across developmental stages (overall, 17%, 10%, 7%, and 3%, 
respectively). Boys had higher IA and HI symptom counts than girls, although symptom 
persistence patterns were similar between sexes.
Some participants were counted in this figure multiple times within each developmental 
stage. Therefore, Figure 2 allows for a simple visual inspection of the symptom counts that 
were later modeled, but does not sufficiently account for the longitudinal characteristic of 
the data. All models accounted for the correlation between each participant’s symptom 
counts across data collection points. Median IA and HI symptom counts at Time 1 were 
similar between those who did and did not participate in follow-up, providing evidence that 
the apparent patterns over time were not due to cohort attrition.
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The top portion of Table 2 shows results of the logistic quantile regression models in which 
percentiles of IA symptom count were modeled as a function of age (continuous) and 
adjusted for associated demographic factors. Odds ratios (OR) can be interpreted similarly to 
those from logistic regression for the probability of binary outcomes, with the probability 
replaced by the quantile-to-interval-length ratio. For example, the odds of having an IA 
symptom count in the 80th percentile was 0.25 smaller for females than for males. IA 
symptom count did not differ independently by age at any fifth percentile (upper quartile 
shown). Those using ADHD medication, and those with psychiatric disorder other than 
ADHD, and, to some extent, those living in a single parent household were more likely to 
have a higher IA symptom count.
This modeling approach was also performed using HI symptom count (bottom of Table 2). 
The upper quartile of HI symptom count significantly decreased by age after adjustment for 
associated demographics, although we were unable to detect a significant decrease in any 
value of HI symptom count below the 75th percentile (data not shown). Demographic 
factors were similarly associated with high levels of IA and HI symptoms. There was no 
evidence of a significant interaction between age and sex at any modeled percentile, 
meaning symptom persistence patterns did not differ between boys and girls in this sample.
The co-existence of IA and HI symptoms were also examined. At Time 1, 41% of children 
with high (≥6) IA symptom counts also had high HI symptom counts, and 73% of children 
with high HI symptom counts also had high IA symptom counts. An unadjusted logistic 
regression model suggested that among those with high HI symptom counts at Time 1, high 
HI symptom counts were more likely to persist in participants who had high IA symptom 
counts (OR = 3.3; 95% CI [1.0, 10.7]; p = .05). Although high IA symptom counts more 
often persisted among participants who had high HI symptom counts, this association was 
not statistically significant.
Discussion
The data for this study were collected as part of a large community-based project examining 
the prevalence and correlates of ADHD in school-aged children. The prevalence of parent-
reported IA and HI symptoms was similar in early childhood. After adjustment for sex, 
ADHD medication use, and presence of another psychiatric disorder, IA symptom count did 
not differ with age, but the highest quartile of HI symptom counts did decrease with age. 
High HI symptom counts may be more likely to persist among those who also have high IA 
symptom counts. Symptom counts were positively associated with ADHD medication use 
and psychiatric comorbidity, although this is likely due to higher likelihood of youth with 
high ADHD symptom counts and/or a psychiatric disorder other than ADHD being placed 
on medication.
Building on prior research, this study extends the findings from Todd et al. (2008) who 
likewise studied a community-based sample, although using data from two time points 5 
years apart. Similar to Todd et al., the present study reported inattentive symptoms tended to 
persist more than HI symptoms, although the present study utilized more frequently 
collected data over a broader age range to examine detailed patterns from early childhood 
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through late adolescence. Also consistent with prior research, this study shows a higher level 
of ADHD symptomatology in boys than in girls. However, this study is able to add that the 
developmental course of the symptoms appears to be similar among boys and girls. 
Therefore, girls with high levels of symptoms were as likely as boys to show symptom 
persistence across development in this community-based sample. It is possible that the 
apparent difference in the developmental trajectory between IA and HI symptom counts 
partially reflects differences in environmental context. That is, aspects of HI are more 
apparent at young ages, while the recognition of IA often does not surface until tasks at 
school or work tax attentional capacity (Faraone et al., 2006; Kessler et al., 2006). In 
addition, it is possible that a portion of the HI symptom decline is because of the symptom 
descriptors used in DSM-IV that generally did not apply to adolescent behaviors. This has 
been addressed in DSM-5 (APA, 2013), as additional examples have been included in 
DSM-5 to illustrate types of behaviors adolescents and adults with ADHD may exhibit. 
Findings from this study lend support for recognition of ADHD as a disorder affecting 
people beyond childhood.
There are at least three important limitations of this study. First, defining remission, relapse, 
persistence, and desistance is central to both conducting persistence studies and interpreting 
their findings, particularly in psychiatric research (Eaton, 2002). Because researchers 
continue to define these measures differently, it is difficult to compare our results with the 
work of others. Another important limitation is our insufficient power to detect potential 
differences in symptom persistence patterns by demographic subgroups, such as race/
ethnicity. Third, this study relies entirely on parent-reported symptoms because we did not 
have adequate data from other informants, most notably teachers.
This study also has notable strengths. To build on previous studies (Biederman et al., 2010; 
Faraone et al., 2006; Hart et al., 1995; Mannuzza, Klein, & Moulton, 2003), this study 
investigated symptom patterns of inattentive, hyperactive, and impulsive DSM-IV symptoms 
among both boys and girls from a diverse community-based sample. A second major 
strength of this study is the novel use of logistic quantile regression, which more 
appropriately handles dependent variables that are bounded with skewed distributions (i.e., 
symptom counts), allows for valid interpretation of estimates at extreme ends of the 
distribution (e.g., the 95th percentile), and makes no assumptions related to scale of the 
variable itself. This community-based study was also strengthened by the application of 
sample and non-response weights, which allow estimates to be considered generalizable to 
the base population, in this case, the school district from which the sample was drawn.
This study’s findings have important clinical implications. Results from this study provide 
greater context for clinicians who treat children outside of the elementary school age, 
including adolescents who had not been previously diagnosed (Faraone, Spencer, Montano, 
& Biederman, 2004). Specifically, this study suggests that HI symptoms often remit but that 
IA symptoms generally persist into adolescence. Given the negative outcomes associated 
with adolescent ADHD (Barbaresi et al., 2007; Flory et al., 2006; Jerome et al., 2006; 
Küpper et al., 2012; Loe & Feldman, 2007; Molina et al., 2013), close clinical attention 
should be paid to the assessment of inattentive symptoms, in particular, during the 
evaluation and treatment of adolescent patients, which can be more difficult to identify. 
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Notably, fewer symptoms are now required to meet a diagnosis of ADHD among older 
adolescents and young adults (17 years of age and older) with ADHD (APA, 2013); 
therefore, careful assessment of IA symptoms among adolescents may have a measureable 
impact on the prevalence of ADHD among adolescents. In addition, previous brain imaging 
research has identified groups of children who appear to have remitting ADHD (Shaw et al., 
2006); this study reveals symptom persistence patterns that may further characterize the 
phenotypes of remitting and persistent childhood ADHD. Finally, this information may be 
helpful for clinicians who seek to provide anticipatory guidance to parents of children who 
are newly diagnosed with ADHD and have questions about the persistence of ADHD and its 
symptoms over time.
Characterizing the course of ADHD symptoms in the community is an important Public 
Health activity, which leads to greater understanding of this common chronic disorder. 
Understanding symptom persistence may also inform the development of early prevention 
and targeted treatment strategies, inform educators on what to expect within the classroom, 
and inform efforts to educate parents on what to expect from their child’s ADHD symptoms 
over time. The findings of this study provide support for the importance of ongoing 
monitoring of ADHD and its symptoms through adolescence. Although ADHD is no longer 
recognized solely as a childhood disorder, there is very little research on ADHD persistence 
among older adolescents and young adults, and it is important that future efforts address this 
gap, particularly as the epidemiology of childhood ADHD continues to evolve (Visser et al., 
2014) and the prevalence estimates of adult ADHD increase (Kessler et al., 2006).
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Prevalence of parent-reported ADHD symptoms by developmental stage.
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Distribution of symptom counts by sex (male: textured) and developmental stage.
Note. The white line within each bar separates those who had ≥6 symptoms
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